Effect of an Acute Incremental Exercise on Plasma Peptide YY, Neuropeptide Y and IGF-1 Concentrations in Young Athletes

Authors

  • Hassan Faraji Department of Physical Education and Sport Science, Mariwan Branch, Islamic Azad University
  • Rahman Rahimi Department of Physical Education and Sport Science, Kurdistan University
Abstract:

This study aims to determine the effect of a single exhausting exercise on plasma PYY, NPY and IGF-1 in young athletes. Thirty-one young athletes (aged 19.52±2.75 years, body mass 79.24±16.13 kg, height 173±6.49 cm, and body fat 16.37±5.92%) volunteered to participate in this study. The participations, in randomized crossover manner, performed a single exercise bout on a cycle ergometer at 50 watts (W) for five-minute, and the power output was increased by 30 W every 3 minute until voluntary exhaustion. Venous blood samples were collected before (Pre), immediately after (Post) and 1h after (1h Post) exercise to assess plasma PYY, NPY and IGF-1concentrations. Plasma PYY (p=0.042) and IGF-1 (p=0.001) significantly increased at Post exercise. Also, NPY was increased Post (p=0.001) and for 1h Post (p=0.021) exercise. The exhausting exercise increase plasma PYY concentration and this increase may relate to IGF-1 signals in young athletes. However, increased plasma NPY may not be related to stimulation food intake because it does not penetrate the blood-brain barrier.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Study of the effects of Neuropeptide Y injections on plasma concentrations of Thyroxine and triiodothyronine in goat

Introduction: Neuropeptide Y (NPY) is the most abundant peptide present in mammals' brains. The majority of NPY-producing neurons is in arcuate and paraventricular nuclei of hypothalamus which affect hypophysiotrapic factors secretion. In this study we investigated the effect of intravenous injections of various doses of NPY on thyroxine (T4) and triiodothyronine (T3) serum concentrations. ...

full text

Chicken neuropeptide Y-family receptor Y4: a receptor with equal affinity for pancreatic polypeptide, neuropeptide Y and peptide YY.

Within the neuropeptide Y (NPY) family of peptides, pancreatic polypeptide is the most divergent across species. It differs in 20 of 36 positions between human and chicken. In mammals, it binds primarily to the Y4 receptor, to which NPY and peptide YY (PYY) bind with lower affinities. Because of these large sequence differences in pancreatic polypeptide, we decided to characterise the chicken Y...

full text

Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients.

BACKGROUND Disturbances of leptin, neuropeptide Y (NPY), and peptide YY (PYY) have been found in women who are ill with anorexia or bulimia nervosa. It is not certain whether peptide disturbances are cause or consequence of eating disorders. METHODS Plasma leptin and cerebrospinal fluid leptin, NPY, and PYY concentrations were measured in women who were recovered from anorexia or bulimia nerv...

full text

Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut–brain axis

The gut-brain axis refers to the bidirectional communication between the gut and the brain. Four information carriers (vagal and spinal afferent neurons, immune mediators such as cytokines, gut hormones and gut microbiota-derived signalling molecules) transmit information from the gut to the brain, while autonomic neurons and neuroendocrine factors carry outputs from the brain to the gut. The m...

full text

Neuropeptide Y and peptide YY protect from weight loss caused by Bacille Calmette–Guérin in mice

BACKGROUND AND PURPOSE Immune challenge of mice with Bacille Calmette-Guérin (BCG) has been reported to cause transient weight loss and a behavioural sickness response. Although BCG-induced depression involves the kynurenine pathway, weight loss occurs independently of this factor. Because neuropeptide Y (NPY) and peptide YY (PYY) are involved in the regulation of food intake, we hypothesized t...

full text

Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.

1229U91 (GW1229 or GR231118) [lle,Glu,Pro,Dpr,Tyr, Arg,Leu,Arg, Tyr-NH(2))2 cyclic (2,4'),(2'4)-diamide] has been reported by several research groups to be a potent antagonist at the Y1 neuropeptide Y (NPY) receptor subtype. However, 1229U91 also displaces (125)I-peptide YY (PYY) with high affinity from the Y4 subtype. Previously, we reported that 1229U91 had full agonist properties for the Y4 ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 2  issue None

pages  23- 32

publication date 2014-10

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023